National Payer Access Director – Biosimilars (Remote)

Makonis; United States; Remote; USD 180,000 - 260,000; Full time

Job summary

Makonis is seeking a Payer, National Account Director – USA (Remote) to lead payer-facing initiatives across the United States. The role reports to the VP for Access & Alliance Management and focuses on designing strategic plans for payer engagement, formulary positioning, and contracting to secure product access for providers and patients.

The ideal candidate has 12+ years as a National Account Manager in pharma, with monoclonal antibody biosimilars experience, and excels in negotiation,

Qualifications

• Bachelor's degree in economics, business management, business science or equivalent.
• Minimum 12 years of experience as National Account Manager (payer-facing).
• Pharmaceutical industry experience required, especially monoclonal antibody biosimilars.
• Strong negotiation and presentation capabilities.

Responsibilities

• Develop strategic product launch strategy and plans to expedite payer access in the United States.
• Understand payer goals and develop resources to meet needs.
• Monitor nationwide and regional coverage and policy changes.
• Provide guidance on trends, market dynamics, and policy implications for payer access.
• Collaborate with HEOR, Sales & Marketing, Contracting, and Business Management to gain market access with payers.

Skills

Verbal communication

Written communication

Negotiation

Presentation

Cross-functional collaboration

Confidentiality & integrity

Education

Economics degree

Business Management degree

Job description

Makonis is seeking a Payer, National Account Director – USA (Remote) to lead payer-facing initiatives across the United States. The role reports to the VP for Access & Alliance Management and focuses on designing strategic plans for payer engagement, formulary positioning, and contracting to secure product access for providers and patients.

The ideal candidate has 12+ years as a National Account Manager in pharma, with monoclonal antibody biosimilars experience, and excels in negotiation,